Xtrackers Nifty 500 India ETF（IND）ETF 价格、持仓与基金资料

US$23.02

+US$0.08 · +0.35%

2026年8月21日 09:30 – 2026年8月21日 15:20美国东部时间ET

区间最低: US$22.8635
区间最高: US$23.02

盘中时间采用ET。市场数据可能有所延迟。

关于此 ETF

This fund is designed to deliver investment returns that closely reflect the performance of the Nifty 500 Index. Its primary objective is to track the movements of this benchmark, measured before any of the fund's own management fees or operational expenses are subtracted.

资产类别: Equity
发行方: Xtrackers
注册地: US
成立日期: 2025年11月25日
持仓数量: 498
ISIN: US23306X7874

主要基金统计

基金资产

460.62万 USD

费用率

0.19%

NAV

US$23.03

平均成交量

942

成交量

99

当日区间

US$22.995 – US$22.995

52 周区间

US$20.515 – US$27.40

前收盘价

US$22.94

价格变动

表现

1 天

+0.24%

1 个月

+3.77%

3 个月

+3.30%

年初至今

-7.72%

1 年

-8.75%

3 年

-8.75%

5 年

+5648.75%

价格变动不包括分派、费用、税费及投资者特定的现金流。

投资组合

主要持仓

排名持仓代码权重

01

HDFC BANK LTDHDFCBANK.BOHDFCBANK.BO5.38%

02

ICICI Bank LtdICICIBANK.BOICICIBANK.BO4.95%

03

RELIANCE INDUSTRIESRELIANCE.BORELIANCE.BO4.29%

04

Bharti Airtel LtdBHARTIARTL.BOBHARTIARTL.BO2.86%

05Cash & Cash Equivalents——2.49%

06

Larsen & Toubro LtdLT.BOLT.BO2.33%

07

State Bank Of IndiaSBIN.BOSBIN.BO2.12%

08

Infosys LtdINFY.BOINFY.BO1.90%

09

Axis Bank LtdAXISBANK.BOAXISBANK.BO1.74%

10Y54Mahindra & Mahindra LtdY54164150Y541641501.48%

11

KOTAK MAHINDRA BANK LTD INR 1.0KOTAKBANK.BOKOTAKBANK.BO1.44%

12

BAJAJ FINANCE LTD NPVBAJFINANCE.BOBAJFINANCE.BO1.42%

13

ITC LtdITC.BOITC.BO1.26%

14

Zomato LtdETERNAL.BOETERNAL.BO1.14%

15

TATA CONSULTANCY SVCS LTDTCS.BOTCS.BO1.14%

持仓数据更新于 2026年8月23日。

投资组合构成

敞口

国家敞口

前 3 项

India96.16%

Other3.20%

United States0.65%

基金收益

分派

除息日登记日支付日金额

2026年6月18日

Irregular

2026年6月18日

2026年6月26日

US$0.078

Irregular

IND 新闻

gurufocus.com2026年8月16日

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

[url="]Faruqi and Faruqi, LLP[/url], a leading national securities law firm, is investigating potential claims against Aardvark Therapeutics, Inc. (âAardvarkâ

阅读源码

gurufocus.com2026年8月6日

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines

阅读源码

gurufocus.com2026年7月13日

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia

[url="]Niagen Bioscience, Inc.[/url] (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy ag

阅读源码

gurufocus.com2026年7月9日

JetBlue Launches Largest-Ever Fort Lauderdale Schedule, Reinforcing Long-Term Commitment to South Florida

JetBlue (NASDAQ: JBLU) today continued its significant expansion at Fort Lauderdale-Hollywood International Airport (FLL), with the launch of eight nonstop des

阅读源码

gurufocus.com2026年6月9日

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program PR News

阅读源码

gurufocus.com2026年6月2日

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

[url="]Imagion Biosystems, Ltd. (ASX: IBX)[/url] has announced that the US Food and Drug Administration (FDA) completed its review of the company's investigati

阅读源码

更多基金

探索更多 ETF

浏览全部 ETF

Vanguard Total International Stock ETF

VXUS

US$87.71

+0.78%

Invesco QQQ Trust, Series 1

QQQ

US$713.44

+0.35%

BNY Mellon Municipal Opportunities ETF

BMOP

US$24.685

-0.06%

Vanguard Total Bond Market ETF

BND

US$72.23

-0.15%

SPAC and New Issue ETF

SPCK

US$22.19

-0.27%

Vanguard Total International Bond ETF

BNDX

US$47.65

0.00%

正在加载 ETF 研究

Xtrackers Nifty 500 India ETF

关于此 ETF

主要基金统计

表现

主要持仓

敞口

国家敞口

分派

IND 新闻

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia

JetBlue Launches Largest-Ever Fort Lauderdale Schedule, Reinforcing Long-Term Commitment to South Florida

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

探索更多 ETF

继续研究 IND

正在加载 ETF 研究

Xtrackers Nifty 500 India ETF

IND ETF 概览

关于此 ETF

主要基金统计

表现

主要持仓

敞口

国家敞口

分派

IND 新闻

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia

JetBlue Launches Largest-Ever Fort Lauderdale Schedule, Reinforcing Long-Term Commitment to South Florida

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

探索更多 ETF

继续研究 IND